...
首页> 外文期刊>Archives of Toxicology >Changes in the glutathione system of lung cell lines after treatment with hydrocortisone.
【24h】

Changes in the glutathione system of lung cell lines after treatment with hydrocortisone.

机译:氢化可的松治疗后肺细胞系谷胱甘肽系统的变化。

获取原文
获取原文并翻译 | 示例

摘要

Administration of anti-inflammatory glucocorticoids is a drug option in the therapy of acute respiratory distress syndrome (ARDS), according to present pathophysiological concepts. Surprisingly, glucocorticoids failed to show beneficial effects. This failure is not understood. In this investigation changes in the glutathione system due to hydrocortisone were found to consist of glutathione depletion and lowered glutathione reductase activities in alveolar epithelial type II cells, contrasted with unchanged activities in a fibroblast-like lung cell line. The glutathione system is thought to be the most important cellular antioxidative system and therefore alveolar epithelial type II cells might be more susceptible to oxidative stress after glucocorticoid treatment. As alveolar epithelial type II cells may be important targets in ARDS, because of their functions (stem cells of type I epithelial cells; surfactant synthesis), these changes might provide an explanation for the failure of glucocorticoids. Inthe present experiments the capability of hydrocortisone-treated alveolar epithelial type II cells to synthesise glutathione was found to be cysteine dependent at physiological concentrations. Transposing this observation to the in vivo situation, it might be expected that glucocorticoid efficacy in ARDS therapy requires co-administration of substances that increase glutathione synthesis, e.g. N-acetylcysteine.
机译:根据目前的病理生理学概念,抗炎糖皮质激素的给药是治疗急性呼吸窘迫综合征(ARDS)的一种药物选择。令人惊讶的是,糖皮质激素未能显示出有益的作用。无法理解此故障。在这项研究中,发现氢化可的松导致的谷胱甘肽系统变化包括Ⅱ型肺泡上皮细胞中的谷胱甘肽耗竭和谷胱甘肽还原酶活性降低,而成纤维细胞样肺细胞系的活性未改变。谷胱甘肽系统被认为是最重要的细胞抗氧化系统,因此糖皮质激素治疗后,II型肺泡上皮细胞可能更容易受到氧化应激。由于II型肺泡上皮细胞可能是ARDS的重要靶标,因为其功能(I型上皮细胞的干细胞;表面活性剂合成),这些变化可能为糖皮质激素的失败提供了解释。在本实验中,发现氢化可的松处理的II型肺泡上皮II型细胞合成谷胱甘肽的能力在生理浓度下是半胱氨酸依赖性的。将这一观察结果转化为体内情况,可以预期在ARDS治疗中糖皮质激素的功效需要与谷胱甘肽合成增加的物质共同给药,例如在体内。 N-乙酰半胱氨酸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号